4.4 Article

Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Immunology

The T cell immune response against SARS-CoV-2

Paul Moss

Summary: T cell immunity plays a central role in controlling SARS-CoV-2 infection, with early responses correlating with protection. T cell memory provides broad recognition of viral proteins, limiting the impact of viral variants and offering protection against severe disease. Current COVID-19 vaccines elicit robust T cell responses, contributing to the prevention of hospitalization or death. Therefore, the importance of T cell immunity may have been underestimated.

NATURE IMMUNOLOGY (2022)

Article Immunology

BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2

R. Camille Brewer et al.

Summary: This study investigated the B cell response to the BNT162b2 vaccine by integrating B cell repertoire analysis with single-cell transcriptomics pre- and post-vaccination. It found that the first vaccine dose generated a recall response of IgA(+) plasmablasts targeting the S subunit S2, while the second dose strongly boosted this response and produced potent neutralizing antibodies against SARS-CoV-2 and its variants.

NATURE IMMUNOLOGY (2022)

Article Immunology

Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19

Anna H. E. Roukens et al.

Summary: Systemic immune cell dynamics during COVID-19 have been well-documented, but less is known about immune cells in the respiratory tract. This study characterized nasal and systemic immune cells in COVID-19 patients, showing increased inflammatory cells in the nasal mucosa during acute infection. After recovery, nasal immune cells mostly normalized, but SARS-CoV-2-specific CD8(+) T cells could persist for at least 2 months.

NATURE IMMUNOLOGY (2022)

Article Microbiology

Combined Prospective Seroconversion and PCR Data of Selected Cohorts Indicate a High Rate of Subclinical SARS-CoV-2 Infections-an Open Observational Study in Lower Saxony, Germany

Rebecca Jonczyk et al.

Summary: This observational study in Germany suggests that PCR testing of individuals without or with few symptoms of COVID-19 can help manage the pandemic. The study found a relatively high rate of subclinical SARS-CoV-2 infections, indicating that systematic screening of asymptomatic individuals through PCR testing can significantly reduce the spread of the virus, in addition to other intervention strategies.

MICROBIOLOGY SPECTRUM (2022)

Article Multidisciplinary Sciences

SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity

Wuji Zhang et al.

Summary: This study compares the immune response in peripheral blood and respiratory samples of COVID-19 patients, revealing differential immune responses between these compartments. Specific antibodies against SARS-CoV-2 are more pronounced in respiratory specimens and correlate with neutralization activity. Additionally, inflammation, immune subsets, and drug therapy impact the immune response.

NATURE COMMUNICATIONS (2022)

Review Immunology

The role of T cells in age-related diseases

Elisa Carrasco et al.

Summary: T cells play a crucial role in age-related diseases, potentially leading to the failure of immune tolerance mechanisms and tissue damage. Targeting T cells could offer new therapeutic opportunities to enhance resilience to age-related diseases.

NATURE REVIEWS IMMUNOLOGY (2022)

Article Cell Biology

Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients

Anthony T. Tan et al.

Summary: This study found that early induction of interferon-gamma (IFN-gamma) secreting SARS-CoV-2-specific T cells was present in patients with mild disease and accelerated viral clearance, while rapid induction and quantity of humoral responses were associated with an increase in disease severity. These findings highlight the importance of early functional SARS-CoV-2-specific T cells in both vaccine design and immune monitoring.

CELL REPORTS (2021)

Article Biochemistry & Molecular Biology

Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection

Elizabeth M. Anderson et al.

Summary: Our research indicates that most individuals had antibodies against other seasonal human coronaviruses before the COVID-19 pandemic. Around 20% of these individuals also had antibodies that cross-reacted with SARS-CoV-2, but these antibodies did not offer protection against SARS-CoV-2 infections or hospitalizations.
Article Multidisciplinary Sciences

Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection

Xiao-Lin Jiang et al.

Summary: The majority of SARS-CoV-2-infected patients maintain IgG, neutralising antibody, and T cell responses for at least 3-4 months post-infection, while IgM levels largely decrease during this time period.

NATURE COMMUNICATIONS (2021)

Article Geriatrics & Gerontology

Unanticipated efficacy of SARS-CoV-2 vaccination in older adults

Graham Pawelec et al.

Summary: The rapid development and testing of COVID-19 vaccines have shown high efficacy in older adults, potentially leading to a paradigm shift in understanding the impact of immunosenescence on vaccination against novel infectious diseases.

IMMUNITY & AGEING (2021)

Article Immunology

Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People

Julie Demaret et al.

Summary: This study found that COVID-19-naive older individuals had lower antibody counts and impaired specific CD4(+) and CD8(+) T cells following vaccination, while COVID-19-recovered older individuals exhibited stronger antibody and T-cell responses post-vaccination. Additionally, high plasma levels of TNF alpha were associated with poor antibody response in older participants.

FRONTIERS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

Review Immunology

Aging and Options to Halt Declining Immunity to Virus Infections

Miguel angel Palacios-Pedrero et al.

Summary: Immunosenescence is a process associated with aging that leads to dysregulation of immune cells, increasing susceptibility to infections and reducing vaccine efficacy in older adults. Understanding immunosenescence can help in developing new strategies to enhance immune function in this vulnerable age group.

FRONTIERS IN IMMUNOLOGY (2021)

Article Infectious Diseases

Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021

Clara Mazagatos et al.

Summary: The study found that the effectiveness of mRNA COVID-19 vaccines for elderly residents in long-term care facilities in Spain was estimated at 71%, 88%, and 97% against SARS-CoV-2 infections, COVID-19 hospitalizations, and deaths, respectively.

EUROSURVEILLANCE (2021)

Article Multidisciplinary Sciences

Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2

Dami A. Collier et al.

Summary: Elderly individuals, especially those above eighty, show lower immune responses and neutralization abilities against variants of concern after the first vaccine dose, but this improves after the second dose. They have higher frequencies of spike-specific memory B cells but reduced somatic hypermutation of class-switched cells. Production of interferon-gamma and interleukin-2 by SARS-CoV-2 spike-specific T cells is lower in older participants, predominantly by CD4 T cells.

NATURE (2021)

Article Biochemistry & Molecular Biology

Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy

Sokratis A. Apostolidis et al.

Summary: Patients with multiple sclerosis on anti-CD20 monotherapy exhibit significantly reduced SARS-CoV-2-specific antibodies and memory B cells, while CD4(+) and CD8(+) T cells are robustly activated compared to healthy controls after receiving BNT162b2 or mRNA-1273 mRNA vaccination.

NATURE MEDICINE (2021)

Article Multidisciplinary Sciences

Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination

Lucie Loyal et al.

Summary: The study demonstrates that preexisting spike-cross-reactive T cells play a functional role in the immune response to SARS-CoV-2 infection and vaccination. Cross-reactive immunity may explain the rapid induction of immunity after primary SARS-CoV-2 immunization and the high rate of asymptomatic or mild COVID-19 cases.

SCIENCE (2021)

Article Multidisciplinary Sciences

Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells

Jose Mateus et al.

Summary: This study examined the immune responses to the Moderna mRNA-1273 vaccine over 7 months, finding that subjects with preexisting cross-reactive T cell memory exhibited stronger CD4(+) T cell and antibody responses to the vaccine. This demonstrates the biological relevance and potential importance of cross-reactive T cells in generating immunity to SARS-CoV-2.

SCIENCE (2021)

Article Immunology

Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects

Eleonora Gallerani et al.

Summary: Research indicates that older individuals have defective primary SARS-CoV-2-specific CD8(+) T-cell responses, with lower magnitude and quality compared to younger adults, as well as recognizing a lower number of epitopes.

FRONTIERS IN IMMUNOLOGY (2021)

Article Public, Environmental & Occupational Health

Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years — COVID-NET, 13 States, February–April 2021

Heidi L. Moline et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Article Biochemistry & Molecular Biology

The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity

Leiqiong Gao et al.

Summary: Asymptomatic or mildly symptomatic COVID-19 patients failed to generate strong and prolonged humoral immune responses, while moderate or severe patients often induced potent cellular immune responses but had lower immunity levels.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Allergy

Influence of immune aging on vaccine responses

Claire E. Gustafson et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Carolyn Rydyznski Moderbacher et al.

Article Multidisciplinary Sciences

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Ugur Sahin et al.

NATURE (2020)

Article Multidisciplinary Sciences

Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63

Giulietta Saletti et al.

SCIENTIFIC REPORTS (2020)

Review Immunology

Mechanisms underlying T cell ageing

Jorg J. Goronzy et al.

NATURE REVIEWS IMMUNOLOGY (2019)

Review Immunology

The twilight of immunity: emerging concepts in aging of the immune system

Janko Nikolich-Zugich

NATURE IMMUNOLOGY (2018)

Review Biochemistry & Molecular Biology

Markers of T Cell Senescence in Humans

Weili Xu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Review Immunology

T-cell quality in memory and protection: implications for vaccine design

Robert A. Seder et al.

NATURE REVIEWS IMMUNOLOGY (2008)